Harvard Bioscience Schedules Third Quarter 2026 Earnings Conference Call for November 10, 2026 at 8:00 AM ET

What happened

Harvard Bioscience will report financial results for the quarter ended September 30, 2026, before the market opens on November 10, 2026, and will hold a conference call to discuss the results that day at 8:00 a.m. Eastern Time.

Confirmed

Global impact / market context

Quarterly results show how much revenue Harvard Bioscience earned and what costs it paid, which helps investors judge whether the business is growing. The call also lets analysts ask questions about spending, cash available and demand from pharmaceutical and research customers.

Analyst inference

Harvard Bioscience sells tools and services used in life science research, drug discovery and preclinical testing, with operations in the United States, Europe and China. Its results can signal whether academic, government and pharmaceutical customers are still spending on lab equipment.

Analyst inference

What to watch

1. Harvard Bioscience plans to release its third quarter 2026 earnings release and a related slide presentation on the Investor Relations section of its website. Confirmed
2. Watch whether revenue grew and whether costs rose faster than sales, because that would reduce profit per sale and leave less cash available for research and development. Analyst inference
3. Analysts who want to ask questions on the call must register in advance to receive dial-in numbers and a unique PIN number. Proposed

Evidence

• globenewswire.com